Compound Profile: Duratia 90 Fortune Health Care
Duratia 90 is a dapoxetine-based pharmaceutical formulation manufactured by Fortune Health Care, containing 90mg of the active compound per unit. Dapoxetine is a selective serotonin reuptake inhibitor (SSRI) that belongs to the benzisoxazole class of compounds. This research-grade material enables laboratory investigation of serotonin transport mechanisms and neurochemical modulation pathways. The compound demonstrates rapid onset and short half-life properties in preclinical models, making it valuable for studying acute serotonin system perturbations. Researchers at Stroid UK Shop have access to verified analytical standards for comprehensive neurochemical studies.
Laboratory Research Applications
This dapoxetine formulation serves as an essential tool for studying selective serotonin reuptake inhibition in controlled laboratory environments. Researchers examine its binding affinity to serotonin transporters and evaluate its pharmacokinetic properties in tissue culture systems. The compound’s unique pharmacological profile allows scientists to investigate rapid-onset SSRI mechanisms compared to traditional longer-acting compounds. Studies utilise Duratia 90 to analyse neurotransmitter modulation pathways and receptor interaction dynamics. Research teams exploring erection drugs and dapoxetine compounds find this formulation particularly useful for comparative pharmacological assessments. Additional research applications include investigating serotonergic pathway modulation alongside other compounds available in our SARMS collection and peptide research materials.
Analytical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Dapoxetine |
| Dosage Form | 90mg tablets |
| Manufacturer | Fortune Health Care |
| CAS Number | 119356-77-3 |
| Molecular Formula | C₂₁H₂₃NO |
| Molecular Weight | 305.41 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Classification | SSRI analytical standard |
Research Compliance Statement
Duratia 90 is supplied exclusively for in-vitro laboratory research and analytical purposes. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must maintain appropriate laboratory safety protocols and ensure compliance with institutional research guidelines. All studies should be conducted by qualified personnel in properly equipped facilities with adequate ventilation and safety measures. This product is restricted to professional research applications only and requires appropriate handling procedures consistent with good laboratory practice standards.
